Organic Letters
Letter
and hence cannot generate an active ester of type 8. However,
in the presence of SCDA (i.e., a reaction regime which can
produce difluorocarbene and ester 8) 32% of 9 is observed,
along with a trace quantity of 3a.
The chlorodifluoroacyl group is a valuable synthon for the
construction of vic-difluorinated molecules. To demonstrate the
potential of this simple chlorodifluoroacylation method for the
synthesis of more complex fluoro-organics, we carried out a
selection of transformations shown in Schemes 4 and 5.
ASSOCIATED CONTENT
* Supporting Information
Experimental procedures and characterization data for all new
compounds. This material is available free of charge via the
■
S
AUTHOR INFORMATION
Corresponding Author
■
Notes
Scheme 4. Reaction with O-Nucleophiles
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We thank the EPSRC for funding. Mr. Gareth Smith
(University of Manchester) is thanked for mass spectrometry.
Dr. T. E. Storr (University of Manchester) is thanked for
crystallography.
REFERENCES
■
Scheme 5. Further Transformations of CF2Cl
(1) Reviews: (a) Liang, T.; Neumann, C. N.; Ritter, T. Angew. Chem.,
Int. Ed. 2013, 52, 8214. (b) Hagmann, W. K. J. Med. Chem. 2008, 51,
4359. (c) Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Chem.
Soc. Rev. 2008, 37, 320. (d) Amatamey, S. M.; Honer, M.; Schubiger,
P. A. Chem. Rev. 2008, 108, 1501.
(2) Birchall, J. M.; Cross, G. W.; Haszeldine, R. N. Proc. Chem. Soc.
1960, 81.
(3) (a) Chen, Q.-Y.; Wu, S.-W. J. Chem. Soc., Chem. Commun. 1989,
705. (b) MacNeil, J. G., Jr.; Burton, D. J. J. Fluorine Chem. 1991, 55,
225.
(4) (a) Mulder, J. A.; Frutos, R. P.; Patel, N. D.; Qu, B.; Sun, X.;
Tampone, T. G.; Gao, J.; Sarvestni, M.; Eriksson, M. C.; Haddad, N.;
Shen, S.; Song, J. J.; Snanayake, C. H. Org. Process Res. Dev. 2013, 17,
940. (b) Sperry, J. B.; Farr, R. M.; Levent, M.; Ghosh, M.; Hogland, S.
M.; Varsolona, R. J.; Sutherland, K. Org. Process Res. Dev. 2012, 16,
1854. (c) Sperry, J. B.; Sutherland, K. Org. Process Res. Dev. 2011, 15,
721. (d) Johnson, P. S.; Underwood, T. J.; Wheeler, S. Tetrahedron
Lett. 2011, 52, 3226. (e) Kmentova, I.; Sutherland, H. S.; Palmer, B.
D.; Blaser, A.; Franzblau, S. G.; Wan, B.; Wang, Y.; Ma, Z.; Denny, W.
A.; Thompson, A. M. J. Med. Chem. 2010, 53, 8421. (f) Ando, M.;
Wada, T.; Sato, N. Org. Lett. 2006, 8, 3805. (g) Ho, J. Z.; Elmore, C.
S.; Wallace, M. A.; Yao, D.; Braun, M. P.; Dean, D. C.; Melillo, D. G.;
Chen, C.-Y. Helv. Chim. Acta 2005, 88, 1040.
(5) SCDA is currently available from Sigma-Aldrich at ca. 10% of the
price of Ruppert−Prakash reagent and ca. 2% of Umemoto’s reagent.
(6) Mehta, V. P.; Greaney, M. F. Org. Lett. 2013, 15, 5036.
(7) James, P. N.; Snyder, H. R. Org. Synth. 1959, 39, 30.
(8) Selected examples with fluorinated acyl groups: (a) Kiselyov, A.
S. Tetrahedron Lett. 1995, 36, 4005. (b) Novartis AG. European Patent
EP1783114 A1, Nov 3, 2005.
First, we demonstrated that the self-activation reaction mode
can accommodate O-nucleophiles. Cholesterol (10) gave a 62%
yield of chlorodifluoroacetyl cholesterol ester 11 when
subjected to the standard reaction conditions.17 Second, we
could exemplify some Reformatski chemistry by reacting 3a
with activated zinc in the presence of benzaldehyde. The
reaction proceeded in 79% yield to give the hydroxyketone
12.18 Treatment of 3a with NaSMe in DMSO resulted in SRN
1
substitution of Cl to give 13 (61% yield by 1H NMR).19,20 The
use of these compounds as a starting point for biologically
relevant fluorinated compounds is currently under investiga-
tion.
In conclusion, we have developed a simple method for the
chlorodifluoroacylation of N-methylindoles using inexpensive
SCDA. The method is mild, eschewing activation with
anhydrides, acyl chlorides or strong Lewis acids. Mechanistic
investigations indicate active ester formation via difluorocar-
bene, an unprecedented pathway for this valuable perfluorina-
tion reagent. We are currently exploring the utility of this
reaction in the development of biologically relevant molecules.
(9) (a) Uneyama, K.; Tanaka, H.; Kobayashi, S.; Shioyama, M.; Amii,
H. Org. Lett. 2004, 6, 2733. (b) Biju, P. Synth. Commun. 2008, 38,
1940. (c) Chu, L.; Zhang, X.; Qing, F. L. Org. Lett. 2009, 11, 2197.
(d) Kashikura, W.; Mori, K.; Akiyama, T. Org. Lett. 2011, 13, 1860.
(e) Wu, L. J. Fluorine Chem. 2011, 132, 367. (f) Greico, L. M.;
Halliday, G. A.; Junk, C. P.; Lustig, S. R.; Marshall, W. J.; Petrov, V. A.
J. Fluorine Chem. 2011, 132, 1198. (g) Guo, F.; Wang, R. W.; Qing, F.
L. J. Fluorine. Chem. 2012, 143, 135. (h) Shaozhong, S.; Chaladaj, W.;
Hartwig, J. F. J. Am. Chem. Soc. 2014, 136, 4149.
(10) For related α,α-difluoroimines, see: (a) Verniest, G.; Van
Hende, E.; Surmont, R.; De Kimpe, N. Org. Lett. 2006, 8, 4767.
(b) Ramirez, J.; Fernandez, E. Tetrahedron Lett. 2007, 48, 3841.
(11) For a recent example of the medicinal chemistry uses of
difluoroketones, see: Fah, C.; Mathys, R.; Hardegger, L. A.; Meyer, S.;
Bur, D.; Diederich, R. Eur. J. Org. Chem. 2010, 4617.
(12) Salomon, P.; Zard, S. Z. Org. Lett. 2014, 16, 2926.
C
dx.doi.org/10.1021/ol501854q | Org. Lett. XXXX, XXX, XXX−XXX